We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 60,335 | 08:00:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 15/10/2020 07:57 | No aim stock ever doesn't at some point hit it's placing price unfortunately .... | g2theary | |
| 15/10/2020 07:51 | My avenge is 50p pal, so either way it's win win but I'll definitely be topping up this morning, looking ahead for next 4 weeks this baby will be big and we all know it! Take a look at the last placing back in March when it was at 35p a few weeks later we were at 200p. The funds that are over subscribed will help towards the trails and rolling out the vaccine.GL all and remember syg is a well oiled company with strong fundamentals, stick to fundamentals and ignore the noise from the shorters! | nasnas1 | |
| 15/10/2020 07:48 | Wishful thinking | justtrying1 | |
| 15/10/2020 07:48 | £3 later today | jambam | |
| 15/10/2020 07:47 | Great that the NIHR has informed SNG that the Phase III trial has been badged in the UK as Urgent Public Health and will be recognised as a National Priority study. This begs the question why wasn't the home trial once the hospital results were known!? | tickboo | |
| 15/10/2020 07:44 | May consolidate around 200 pence | amaretto1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
